Drugs / 13C urea
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | EU (EMA) | Helicobacter Test INFAI | — | 1997-08-14 | europa.eu ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05276557 | Nov 2022 → Jun 2023 overdue | Helicobacter pylori infectious disease | ARJ Medical, Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 13C urea | “All children will be exposed to non-radioactive 13C-Urea with citric acid” NCT05276557 ↗1“a single dose of 13C urea at 75mg in powder form” NCT05276557 ↗ |
| Route | Oral | “pre and post 13C ingestion” NCT05276557 ↗ |